This is the authors' abstract. We don't add key points for this paper.
Basosquamous carcinoma (BSC) presents significant therapeutic challenges due to its aggressive behaviour and risk of metastasis. This study evaluates the efficacy of vismodegib, a Hedgehog pathway inhibitor, in treating locally advanced BSC in 18 patients, demonstrating promising complete and partial response rates. The findings provide valuable real-world insights and emphasize the need for further research to guide treatment strategies.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Daponte et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: